News Abbott Laboratories

Equities

ABT

US0028241000

Real-time Estimate Cboe BZX Other stock markets 10:40:46 2024-05-15 am EDT			5-day change	1st Jan Change
104.3 ^USD	+0.29%		-0.55%	-5.19%

May. 09	Drugmaker Abbott India posts Q4 profit rise on higher sales	RE
May. 08	Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Understanding Product-By-Process Claims In Patent Law	May. 14	AQ
Drugmaker Abbott India posts Q4 profit rise on higher sales	May. 09	RE
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing	May. 08	MT
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX	May. 01	AQ
Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee	Apr. 29	MT
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee	Apr. 29	PR
Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126	Apr. 23	MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating	Apr. 22	MT
UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept	Apr. 19	MT
Correction to Health Care Roundup Article	Apr. 18	DJ
RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating	Apr. 18	MT
Raymond James Adjusts Abbott Laboratories' Price Target to $124 From $127, Keeps Outperform Rating	Apr. 18	MT
Health Care Down After Abbott Earnings -- Health Care Roundup	Apr. 17	DJ
Sector Update: Health Care Stocks Retreating Late Afternoon	Apr. 17	MT
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET	Apr. 17	DJ
S&P 500, Nasdaq dip as interest rate concerns, earnings weigh	Apr. 17	RE
Abbott Laboratories Raises Midpoint of 2024 Guidance After First-Quarter Beat	Apr. 17	MT
Top Stories at Midday: U.S. Bancorp, Abbott, Citizens Financial, First Horizon, Prologis, ASML, Travelers Report Earnings; Tesla Asks Shareholders Vote on Musk's Compensation; Eli Lilly Sleep Apnea Drug Trials Hit Primary Endpoints	Apr. 17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Abbott Laboratories

Equities

ABT

US0028241000

Summary

Filters